DoctorApp Launches Second Crowdfunding Campaign Aiming to Raise 500,000 Euros

DoctorApp launches its second crowdfunding campaign on CrowdFundMe with a minimum goal of 100,000 euros, which has already been exceeded thanks to fifteen investors who immediately joined the offer with over 150,000 euros. The maximum goal is 500,000 euros, with a pre-money valuation of 4.73 million.

In 2021, it had raised 350,000 euros with its first equity crowdfunding campaign, again on CrowdFundMe, with a pre-money valuation of 1.55 million, followed by a round of additional 600 thousand euros, of which 400,000 euros from the Apollion Fund.

DoctorApp was founded in 2018 by Alessandro Giraudo and has developed and patented a digital system for managing queues and bookings in medical practices.

The evolution of DoctorApp

DoctorApp was born in 2018 as a booking app for medical visits provided by general practitioners and pediatricians. Since 2023, the company has expanded its target to medical specialists. Today, the market and changes in user habits have led the company to further evolve.

” From a simple booking and appointment management system for the doctor, we are following the path to become a true health portal, with the patient at the center. A series of new services gravitate around the user. The user can now book specialist and nursing visits, access the services offered by partnerships in the area and find the solution to their wellness needs with useful information and insights. The daily and continuous interaction is the real added value.” Giraudo declared.

Among the first investors who believed in the project and immediately decided to invest to support the company are SeedMoney and SocialFare Seed: ” What struck us about this company from the very beginning – says Marco Rizzelli, General Manager of Seed Money and member of the Board of Directors of DoctorApp – is the great expertise of the team and the ability to seize the new opportunities offered by a constantly evolving market. Today we are still alongside Alessandro and his team to support them also in this second crowdfunding campaign.”

A growing business and the potential exit

DoctorApp customers are doctors, clinics, and outpatient clinics who subscribe to annual and monthly subscriptions. As the company and the audience evolve, from 2026 the company will aim to monetize also from the patient with targeted service offers and very precise profiling.

The company currently has over 400,000 active users and more than 100,000 reservations managed quarterly. In 2023, the company’s production value saw a significant increase, with a growth of 215.60% compared to the previous year.

Giraudo is convinced that investing today in DoctorApp’s equity crowdfunding campaign means entering a rapidly expanding market, that of e-health: « among the reasons for investing in us, there is certainly the team, which has always given great proof of foresight and preparation, and the rapidly growing reference market and the results we are generating are the other factors to take into consideration.”

Furthermore, Giraudo confirms the interest in the sector by large national and international corporations, revealing that DoctorApp has several open discussions with primary entities that could lead to the realization of an exit within 36 months.

__

(Featured image by National Cancer Institute via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Crowdfunding buzz. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us